Articles related to Endocrinology, Diabetes, Metabolism

The Medscape Women Physicians Report 2020 reveals that 64% of female physicians prioritize work-life balance, often feeling conflicted between their careers and caregiving responsibilities, necessitating flexible work arrangements and supportive policies.

Hashimoto’s Thyroiditis is linked to a complex array of symptoms ranging from thyroid enlargement and systemic metabolic disruptions to severe fatigue and cognitive decline, highlighting the need for comprehensive diagnostic strategies and personalized treatment plans.

Ozempic, commonly used off-label for weight management, can cause significant facial side effects, termed “Ozempic face,” marked by increased wrinkling and loss of skin elasticity.

Brazzein, now FDA-approved, emerges as a zero-calorie sweetener potentially safe for diabetic and obese populations, requiring further study to validate its health impacts.

In patients with type 2 diabetes and stage 5 chronic kidney disease, the use of SGLT2 inhibitors is associated with a lower risk of initiating dialysis and experiencing major cardiovascular events, providing a promising therapeutic avenue in a population at elevated risk.

Vitamin D supplementation requires careful management to achieve and maintain optimal serum 25(OH)D levels, particularly in populations at risk for deficiency and those with absorption issues.